Sales decline 33.33% to Rs 0.02 crore
Net profit of Genomic Valley Biotech reported to Rs 0.06 crore in the quarter ended September 2022 as against net loss of Rs 0.06 crore during the previous quarter ended September 2021. Sales declined 33.33% to Rs 0.02 crore in the quarter ended September 2022 as against Rs 0.03 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales0.020.03 -33 OPM %-150.00-33.33 -PBDT-0.02-0.01 -100 PBT-0.03-0.06 50 NP0.06-0.06 LPPowered by Capital Market - Live News
Click here to connect with us on WhatsApp
Disclaimer: No Business Standard Journalist was involved in creation of this content
